The weekly litigation news digest is live. Subscribe now

IP Verse

Aminothiazole Derivatives Useful As Antiviral Agents - EP3440063

The patent EP3440063 was granted to Innovative Molecules on Aug 5, 2020. The application was filed on Apr 5, 2017 under application number EP17715722A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3440063

INNOVATIVE MOLECULES
Application Number
EP17715722A
Filing Date
Apr 5, 2017
Status
Opposition Rejected
Feb 9, 2024
Publication Date
Aug 5, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
AICURIS ANTI INFECTIVE CURESMay 5, 2021ETL PATENT UND RECHTSANWALTSGESELLSCHAFTADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2004006076
OPPOSITIONWO0053591
OPPOSITIONWO0147904
OPPOSITIONWO2010114930
OPPOSITIONWO2012160034
OPPOSITIONWO9724343
OPPOSITIONWO9942455

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents